首页> 外文期刊>International Journal of Reproduction, Contraception, Obstetrics and Gynecology >Comparative study: normotensive and preeclampsia mother presenting with imminent symptoms of eclampsia in third trimester of pregnancy
【24h】

Comparative study: normotensive and preeclampsia mother presenting with imminent symptoms of eclampsia in third trimester of pregnancy

机译:比较研究:妊娠三个三个月孕中期征兆的近期症状,呈近期症状

获取原文
           

摘要

Background: This prospective study compares the maternal and fetal outcome in normotensive and preeclampsia mother presenting with imminent symptoms of eclampsia in third trimester. This prospective study was conducted in the department of obstetrics and gynaecology, Government Theni Medical College, Tamil Nadu, India in 2019. Methods: A total 100 antenatal mothers were selected for the study. Group A - 50 known case of preeclampsia presented with imminent symptoms. Group B-50 previously normotensive patients present with imminent symptoms of eclampsia. Maternal and fetal outcome were analysed. Results: Incidence of eclampsia - 0.1%, HELLP syndrome - 0.04%, pulmonary edema - 0.06%, PRES - 0.07%, abruptio placenta - 0.14% and maternal death in Group A was 2% and in Group B was 8%. Maternal complications are more in normotensive women (46%) presented with imminent symptoms than in preeclampsia women (26%) with imminent symptoms. Incidence of IUGR in Group A was 46%, whereas in Group B 12%. Incidence of preterm babies in Group A was 18%, whereas in Group B was 42%. Perinatal death incidence was 2.2% in imminent eclampsia. Conclusions: Because known preeclampsia patients were aware of imminent symptoms and presented early to hospital. Early identification and treatment of this dreadful outcome at the imminent state itself can reduce the complications. In current status on preventive aspect of eclampsia, atypical presentation should also be considered for which new screening and diagnostic tools has to be developed.
机译:背景:这项前瞻性研究比较了规范性和预先透露的母亲和胎儿结果,并在第三个三个月患有巨大的异国普拉明症症状。该预期研究是在2019年印度印度泰米尔纳德邦政府医学院的妇产科和妇科,政府医学院进行的。方法:选择了100种产前母亲进行研究。 A组 - 50例已知的预胰抗呈现出迫在眉睫的症状。 B组预先患有Eclampsia的迫在眉睫的症状。分析母体和胎儿结果。结果:异丙胺症的发病率 - 0.1%,HellP综合征 - 0.04%,肺水肿 - 0.06%,Pres-0.07%,A组胎盘 - 0.14%和A组母体死亡率为2%,B组为8%。母亲并发症更具正常的女性(46%)呈现出迫在眉睫的症状,而不是在预坦克西亚女性(26%)左上症状。 IUGR在A组IUGR的发病率为46%,而B组12%。 A组中早产婴儿的发病率为18%,而B组在B组中为42%。围产期死亡发病率为迫在眉睫的异国植物中的2.2%。结论:由于已知的预坦克西亚患者意识到即将到来的症状并提前呈现给医院。早期识别和治疗迫在眉睫的状态本身可怕的结果可以减少并发症。在日本普拉姆斯的预防性方面的当前状态下,还应考虑非典型演示,以便必须开发新的筛选和诊断工具。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号